drugset / Trial / NCT04786106
Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's
Phase 4
Active not recruiting
40 enrolled
Charitable Union for the Research and Education of Peyronie's Disease
Endo USA Inc., a Keenova Therapeutics Company · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to compare key clinical outcomes of collagenase clostridium histolyticum injections versus surgery for the management of Peyronie's Disease.
Timeline
- Start
- 2020-12-30
- Primary completion
- 2027-02-15
- Completion
- 2027-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | 0.9 mg | Other |